Home / Market News / $ARAY

$ARAY news and market catalysts

The 10 most recent market catalysts affecting $ARAY, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

10 catalysts 2 high impact 8 bullish 1 bearish Healthcare Equipment & Supplies
Nov 15, 2026 Corporate Catalyst Bullish Impact 75
Accuray Completes Financing Transaction with TCW to Strengthen Balance Sheet
Accuray Incorporated announced the completion of a financing transaction with TCW Asset Management Company. This deal involves TCW converting $40 million of existing term loan prin…
Nov 5, 2026 Corporate Catalyst Bullish Impact 65
Accuray Reports Financial Results for First Quarter Fiscal 2027
Accuray Incorporated announced its financial results for the first quarter of fiscal year 2027, specifically detailing a 4% rise in service revenue and a 120 basis point improvemen…
Nov 5, 2026 Corporate Catalyst Bullish Impact 65
Accuray Announces 1-for-40 Reverse Stock Split
Accuray announced a 1-for-40 reverse stock split, effective November 9, 2026, to increase its per-share trading price and meet Nasdaq's minimum bid price requirement. This action i…
Sep 28, 2026 Corporate Catalyst Bullish Impact 75
Accuray shares are trading higher after the company announced t had entered into agreements with Samsung HME America to pursue advanced volumetric imaging capabilities for the CyberKnife System
This headline represents a significant corporate catalyst for Accuray. The partnership with Samsung HME America, a major player in medical technology, lends credibility and resourc…
Sep 28, 2026 Corporate Catalyst Bullish Impact 75
Why Is Accuray Stock Gaining Monday?
Accuray's stock surged due to its collaboration with Samsung NeuroLogica, aiming to integrate advanced volumetric imaging into its CyberKnife system. This is a significant developm…
Sep 28, 2026 Corporate Catalyst Bullish Impact 75
Reported Sunday, Accuray Enters Agreements With Samsung NeuroLogica To Pursue Volumetric Imaging Capabilities For CyberKnife System, Highlighted At ASTRO Annual Meeting
This agreement represents a significant technological advancement for Accuray's CyberKnife system, potentially improving its competitive standing against rivals like Varian and Ele…
Sep 11, 2026 Corporate Catalyst Bullish Impact 65
Accuray Agrees To Acquire RayStation Licenses For $8M From RaySearch Laboratories
Accuray (ARAY) is acquiring $8 million in RayStation licenses from RaySearch Laboratories (RAYB.ST) to bolster its online adaptive radiation therapy offerings. This agreement signi…
Aug 19, 2026 Corporate Catalyst Bullish Impact 75
Accuray Says Not Providing Formal Revenue Or Adjusted EBITDA Guidance For Fiscal 2027 At This Time
Accuray has decided not to issue formal revenue or Adjusted EBITDA guidance for fiscal year 2027, citing a range of external factors including geopolitical developments, internatio…
Aug 19, 2026 Corporate Catalyst Bearish Impact 85
Accuray Q4 EPS $(0.02) Beats $(0.10) Estimate, Sales $100.919M Miss $105.300M Estimate
Accuray's Q4 earnings report presents a mixed picture. While the company managed to beat EPS estimates, suggesting effective cost management or one-time gains, the substantial miss…
Jul 30, 2026 Corporate Catalyst Neutral Impact 85
Reported Earlier, Accuray Reduces Board To 7 Directors, Plans Reverse Stock Split Alongside TCW-Led Financial Restructuring
This headline indicates a significant corporate event for Accuray (ARAY). The reduction in board size often accompanies cost-cutting measures and a streamlined decision-making proc…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.